To include your compound in the COVID-19 Resource Center, submit it here.

Dacogen decitabine: Final Phase III data

Final data from a double-blind, North American Phase III trial in 170

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE